News

Elevated levels of the gut hormone GLP-1 and its receptor may worsen brain inflammation and trigger severe symptoms in patients with neuromyelitis optica spectrum disorder (NMOSD), suggesting GLP-1 ...
Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.
Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...
Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...
Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...
GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...
Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...
A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...
GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...
Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, binge drinking and relapse.
The Bravo TV kingpin has opened up on his experience with the wildly popular Ozempic-like drugs that many have turned to for ...
Andy Cohen has revealed he took a small dose of a "revolutionary" GLP-1 weight loss drug over the summer and lost 25 pounds.